Lapachol, a compound targeting pyrimidine metabolism, ameliorates experimental autoimmune arthritis

The inhibition of pyrimidine biosynthesis by blocking the dihydroorotate dehydrogenase (DHODH) activity, the prime target of leflunomide (LEF), has been proven to be an effective strategy for rheumatoid arthritis (RA) treatment. However, a considerable proportion of RA patients are refractory to LEF...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Peres, RS, Santos, GB, Cecilio, NT, Jabor, VAP, Niehues, M, Torres, BGS, Buqui, G, Silva, CHTP, Costa, TD, Lopes, NP, Nonato, MC, Ramalho, FS, Louzada-Júnior, P, Cunha, TM, Cunha, FQ, Emery, FS, Alves-Filho, JC
Format: Journal article
Język:English
Wydane: BioMed Central 2017

Podobne zapisy